Skip to content
Screener

Prestige Consumer Healthcare PBH International OTC Healthcare — Total revenues

Other segment segments

North American OTC Healthcare
$226.21M+6.4%

Similar metrics at other companies

Bausch + Lomb logo
BLCOOTC — Total revenues
$497M+3.1%
Papa John's International logo
PZZAInternational — Total revenues
$45.04M+1.9%
Vistra logo
VSTTransferable PTC revenues — Total revenues
$2M0.0%
nCino, Inc. logo
NCNOInternational — Total revenues
$36.41M+15.3%
H&R Block logo
HRBInternational — Total revenues
$70.12M+16.0%
CuriosityStream logo
CURIInternational — Total revenues
$2.85M-34.6%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands)Three Months Ended June 30, 2026 / North American OTCHealthcareThree Months Ended June 30, 2026 / International OTCHealthcareConsolidated
Total segment revenues*$226,206$39,504$265,710
Cost of sales110,26519,257129,522
Gross profit115,94120,247136,188
Advertising and marketing28,9305,73834,668
Contribution margin$87,011$14,509$101,520
Other operating expenses49,000
Operating income$52,520
* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's international OTC healthcare — total revenues?
Prestige Consumer Healthcare (PBH) reported international OTC healthcare — total revenues of $39.5M in Q2 2026.
How has Prestige Consumer Healthcare's international OTC healthcare — total revenues changed year-over-year?
Prestige Consumer Healthcare's international OTC healthcare — total revenues increased by 6.9% year-over-year, from $36.95M to $39.5M.
What is the long-term trend for Prestige Consumer Healthcare's international OTC healthcare — total revenues?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's international OTC healthcare — total revenues has grown at a 10.2% compound annual growth rate (CAGR), from $118.93M to $175.13M.
What does international OTC healthcare — total revenues mean?
The total gross sales generated by the international OTC healthcare segment before the deduction of cost of sales and operating expenses. This metric measures the top-line performance and market demand for the company's products in international markets. It is the primary indicator of the segment's scale and growth trajectory.

Ask your AI about Prestige Consumer Healthcare's international otc healthcare — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude